{"id":1339,"date":"2025-01-16T17:23:24","date_gmt":"2025-01-16T17:23:24","guid":{"rendered":"https:\/\/amm-journal.org\/?p=1339"},"modified":"2025-01-16T17:23:24","modified_gmt":"2025-01-16T17:23:24","slug":"nanozyme-enabled-treatment-of-cardiovascular-diseases","status":"publish","type":"post","link":"https:\/\/amm-journal.org\/index.php\/2025\/01\/16\/nanozyme-enabled-treatment-of-cardiovascular-diseases\/","title":{"rendered":"Targeted nanozyme-enabled treatment of cardiovascular diseases"},"content":{"rendered":"

Announcing a new publication for Acta Materia Medica<\/em> journal<\/a>. Cardiovascular diseases (CVDs) pose a significant threat to human health due to the high mortality and morbidity rates. Traditional drugs often have limited efficacy due to inherent constraints, such as low bioavailability and notable side effects. As a highly regarded therapeutic strategy, nanotechnology offers new perspectives and means for treating CVDs.<\/p>\n

Nanozyme-based targeted therapeutic drugs specifically address the biological processes in areas affected by CVDs, thereby achieving precise treatment. Compared to traditional drugs, targeted nanozymes offer advantages, such as high efficiency, specificity, controllability, and fewer side effects, showing great efficacy in treating CVDs.<\/p>\n

This paper explores the design strategies and mechanisms of nanozyme-based targeted therapy and introduces its application in key CVDs, such as ischemic stroke, myocardial infarction, and coronary heart disease. The challenges of introducing targeted nanozymes into clinical applications and the future development prospects in the treatment of CVDs are also discussed.<\/p>\n

Read More:\u00a0https:\/\/www.scienceopen.com\/hosted-document?doi=10.15212\/AMM-2024-0046<\/a><\/p>\n

Acta Materia Medica<\/em><\/a> welcomes the submission of research articles, review articles, databases, mini reviews, commentaries, editorials, short communications, case report articles and study protocols.<\/p>\n

Submission Process<\/strong><\/p>\n

Submissions to Acta Materia Medica<\/em> are made using ScholarOne, the online submission and peer review system. Registration and access are available at https:\/\/mc04.manuscriptcentral.com\/ammed<\/a><\/p>\n

Queries about the journal can be sent to editorialoffice@amm-journal.org.<\/p>\n

Please visit https:\/\/amm-journal.org\/<\/a> to learn more about the journal.<\/p>\n

Editorial Board:<\/strong> https:\/\/amm-journal.org\/index.php\/editorial-board\/<\/a><\/p>\n

There are no author submission or article processing fees.<\/p>\n

Follow Acta Materia Medica <\/em><\/strong>on Twitter https:\/\/twitter.com\/AMM_journal<\/a>; Facebook<\/a> (https:\/\/www.facebook.com\/AMMjournal<\/a>)<\/p>\n

eISSN <\/strong>2737-7946<\/p>\n

Lin Liu, Jie Lv and Xiuxiu Wang et al. Targeted nanozyme-enabled treatment of cardiovascular diseases.\u00a0Acta Materia Medica.\u00a0<\/em>2025. Vol. 4(1):70-81. DOI: 10.15212\/AMM-2024-0046<\/p>\n","protected":false},"excerpt":{"rendered":"

Announcing a new publication for Acta Materia Medica journal. Cardiovascular diseases (CVDs) pose a significant threat to human health due to the high mortality and morbidity rates. Traditional drugs often have limited efficacy due to inherent constraints, such as low bioavailability and notable side effects. As a highly regarded therapeutic strategy, nanotechnology offers new perspectives […]<\/p>\n","protected":false},"author":5,"featured_media":1340,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[393,228,392,394],"class_list":["post-1339","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-and-events","tag-active-targeting","tag-cardiovascular-diseases","tag-nanozyme-enabled-treatment","tag-nanozymes"],"yoast_head":"\nTargeted nanozyme-enabled treatment of cardiovascular diseases<\/title>\n<meta name=\"description\" content=\"Explore nanozyme-enabled treatment of cardiovascular diseases, highlighting its efficiency, specificity, and potential in overcoming challenges in CVD therapy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/amm-journal.org\/index.php\/2025\/01\/16\/nanozyme-enabled-treatment-of-cardiovascular-diseases\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Targeted nanozyme-enabled treatment of cardiovascular diseases\" \/>\n<meta property=\"og:description\" content=\"Explore nanozyme-enabled treatment of cardiovascular diseases, highlighting its efficiency, specificity, and potential in overcoming challenges in CVD therapy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/amm-journal.org\/index.php\/2025\/01\/16\/nanozyme-enabled-treatment-of-cardiovascular-diseases\/\" \/>\n<meta property=\"og:site_name\" content=\"AMM Journal\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-16T17:23:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/amm-journal.org\/wp-content\/uploads\/2025\/01\/Targeted-nanozyme-enabled-treatment-of-cardiovascular-diseases-FB.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1772\" \/>\n\t<meta property=\"og:image:height\" content=\"1166\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Suresh PDMR\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Suresh PDMR\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/16\\\/nanozyme-enabled-treatment-of-cardiovascular-diseases\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/16\\\/nanozyme-enabled-treatment-of-cardiovascular-diseases\\\/\"},\"author\":{\"name\":\"Suresh PDMR\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/36ab5fda177218467d112d0c1283065e\"},\"headline\":\"Targeted nanozyme-enabled treatment of cardiovascular diseases\",\"datePublished\":\"2025-01-16T17:23:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/16\\\/nanozyme-enabled-treatment-of-cardiovascular-diseases\\\/\"},\"wordCount\":303,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/16\\\/nanozyme-enabled-treatment-of-cardiovascular-diseases\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/amm-journal.org\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Targeted-nanozyme-enabled-treatment-of-cardiovascular-diseases-FB.jpg\",\"keywords\":[\"active targeting\",\"cardiovascular diseases\",\"nanozyme-enabled treatment\",\"nanozymes\"],\"articleSection\":[\"News and Events\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/16\\\/nanozyme-enabled-treatment-of-cardiovascular-diseases\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/16\\\/nanozyme-enabled-treatment-of-cardiovascular-diseases\\\/\",\"url\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/16\\\/nanozyme-enabled-treatment-of-cardiovascular-diseases\\\/\",\"name\":\"Targeted nanozyme-enabled treatment of cardiovascular diseases\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/16\\\/nanozyme-enabled-treatment-of-cardiovascular-diseases\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/16\\\/nanozyme-enabled-treatment-of-cardiovascular-diseases\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/amm-journal.org\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Targeted-nanozyme-enabled-treatment-of-cardiovascular-diseases-FB.jpg\",\"datePublished\":\"2025-01-16T17:23:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/36ab5fda177218467d112d0c1283065e\"},\"description\":\"Explore nanozyme-enabled treatment of cardiovascular diseases, highlighting its efficiency, specificity, and potential in overcoming challenges in CVD therapy.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/16\\\/nanozyme-enabled-treatment-of-cardiovascular-diseases\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/16\\\/nanozyme-enabled-treatment-of-cardiovascular-diseases\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/16\\\/nanozyme-enabled-treatment-of-cardiovascular-diseases\\\/#primaryimage\",\"url\":\"https:\\\/\\\/amm-journal.org\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Targeted-nanozyme-enabled-treatment-of-cardiovascular-diseases-FB.jpg\",\"contentUrl\":\"https:\\\/\\\/amm-journal.org\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Targeted-nanozyme-enabled-treatment-of-cardiovascular-diseases-FB.jpg\",\"width\":1772,\"height\":1166,\"caption\":\"nanozyme-enabled treatment of cardiovascular diseases\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/01\\\/16\\\/nanozyme-enabled-treatment-of-cardiovascular-diseases\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/amm-journal.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Targeted nanozyme-enabled treatment of cardiovascular diseases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#website\",\"url\":\"https:\\\/\\\/amm-journal.org\\\/\",\"name\":\"AMM Journal\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/amm-journal.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/36ab5fda177218467d112d0c1283065e\",\"name\":\"Suresh PDMR\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g\",\"caption\":\"Suresh PDMR\"},\"url\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/author\\\/suresh\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Targeted nanozyme-enabled treatment of cardiovascular diseases","description":"Explore nanozyme-enabled treatment of cardiovascular diseases, highlighting its efficiency, specificity, and potential in overcoming challenges in CVD therapy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/amm-journal.org\/index.php\/2025\/01\/16\/nanozyme-enabled-treatment-of-cardiovascular-diseases\/","og_locale":"en_GB","og_type":"article","og_title":"Targeted nanozyme-enabled treatment of cardiovascular diseases","og_description":"Explore nanozyme-enabled treatment of cardiovascular diseases, highlighting its efficiency, specificity, and potential in overcoming challenges in CVD therapy.","og_url":"https:\/\/amm-journal.org\/index.php\/2025\/01\/16\/nanozyme-enabled-treatment-of-cardiovascular-diseases\/","og_site_name":"AMM Journal","article_published_time":"2025-01-16T17:23:24+00:00","og_image":[{"width":1772,"height":1166,"url":"https:\/\/amm-journal.org\/wp-content\/uploads\/2025\/01\/Targeted-nanozyme-enabled-treatment-of-cardiovascular-diseases-FB.jpg","type":"image\/jpeg"}],"author":"Suresh PDMR","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Suresh PDMR","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/amm-journal.org\/index.php\/2025\/01\/16\/nanozyme-enabled-treatment-of-cardiovascular-diseases\/#article","isPartOf":{"@id":"https:\/\/amm-journal.org\/index.php\/2025\/01\/16\/nanozyme-enabled-treatment-of-cardiovascular-diseases\/"},"author":{"name":"Suresh PDMR","@id":"https:\/\/amm-journal.org\/#\/schema\/person\/36ab5fda177218467d112d0c1283065e"},"headline":"Targeted nanozyme-enabled treatment of cardiovascular diseases","datePublished":"2025-01-16T17:23:24+00:00","mainEntityOfPage":{"@id":"https:\/\/amm-journal.org\/index.php\/2025\/01\/16\/nanozyme-enabled-treatment-of-cardiovascular-diseases\/"},"wordCount":303,"commentCount":0,"image":{"@id":"https:\/\/amm-journal.org\/index.php\/2025\/01\/16\/nanozyme-enabled-treatment-of-cardiovascular-diseases\/#primaryimage"},"thumbnailUrl":"https:\/\/amm-journal.org\/wp-content\/uploads\/2025\/01\/Targeted-nanozyme-enabled-treatment-of-cardiovascular-diseases-FB.jpg","keywords":["active targeting","cardiovascular diseases","nanozyme-enabled treatment","nanozymes"],"articleSection":["News and Events"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/amm-journal.org\/index.php\/2025\/01\/16\/nanozyme-enabled-treatment-of-cardiovascular-diseases\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/amm-journal.org\/index.php\/2025\/01\/16\/nanozyme-enabled-treatment-of-cardiovascular-diseases\/","url":"https:\/\/amm-journal.org\/index.php\/2025\/01\/16\/nanozyme-enabled-treatment-of-cardiovascular-diseases\/","name":"Targeted nanozyme-enabled treatment of cardiovascular diseases","isPartOf":{"@id":"https:\/\/amm-journal.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/amm-journal.org\/index.php\/2025\/01\/16\/nanozyme-enabled-treatment-of-cardiovascular-diseases\/#primaryimage"},"image":{"@id":"https:\/\/amm-journal.org\/index.php\/2025\/01\/16\/nanozyme-enabled-treatment-of-cardiovascular-diseases\/#primaryimage"},"thumbnailUrl":"https:\/\/amm-journal.org\/wp-content\/uploads\/2025\/01\/Targeted-nanozyme-enabled-treatment-of-cardiovascular-diseases-FB.jpg","datePublished":"2025-01-16T17:23:24+00:00","author":{"@id":"https:\/\/amm-journal.org\/#\/schema\/person\/36ab5fda177218467d112d0c1283065e"},"description":"Explore nanozyme-enabled treatment of cardiovascular diseases, highlighting its efficiency, specificity, and potential in overcoming challenges in CVD therapy.","breadcrumb":{"@id":"https:\/\/amm-journal.org\/index.php\/2025\/01\/16\/nanozyme-enabled-treatment-of-cardiovascular-diseases\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/amm-journal.org\/index.php\/2025\/01\/16\/nanozyme-enabled-treatment-of-cardiovascular-diseases\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/amm-journal.org\/index.php\/2025\/01\/16\/nanozyme-enabled-treatment-of-cardiovascular-diseases\/#primaryimage","url":"https:\/\/amm-journal.org\/wp-content\/uploads\/2025\/01\/Targeted-nanozyme-enabled-treatment-of-cardiovascular-diseases-FB.jpg","contentUrl":"https:\/\/amm-journal.org\/wp-content\/uploads\/2025\/01\/Targeted-nanozyme-enabled-treatment-of-cardiovascular-diseases-FB.jpg","width":1772,"height":1166,"caption":"nanozyme-enabled treatment of cardiovascular diseases"},{"@type":"BreadcrumbList","@id":"https:\/\/amm-journal.org\/index.php\/2025\/01\/16\/nanozyme-enabled-treatment-of-cardiovascular-diseases\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/amm-journal.org\/"},{"@type":"ListItem","position":2,"name":"Targeted nanozyme-enabled treatment of cardiovascular diseases"}]},{"@type":"WebSite","@id":"https:\/\/amm-journal.org\/#website","url":"https:\/\/amm-journal.org\/","name":"AMM Journal","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/amm-journal.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/amm-journal.org\/#\/schema\/person\/36ab5fda177218467d112d0c1283065e","name":"Suresh PDMR","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g","caption":"Suresh PDMR"},"url":"https:\/\/amm-journal.org\/index.php\/author\/suresh\/"}]}},"_links":{"self":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/1339","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/comments?post=1339"}],"version-history":[{"count":1,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/1339\/revisions"}],"predecessor-version":[{"id":1341,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/1339\/revisions\/1341"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/media\/1340"}],"wp:attachment":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/media?parent=1339"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/categories?post=1339"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/tags?post=1339"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}